{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:13:07Z","timestamp":1755223987045,"version":"3.43.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,12]]},"DOI":"10.7759\/cureus.89866","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T10:20:37Z","timestamp":1754994037000},"source":"Crossref","is-referenced-by-count":0,"title":["Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis in a Recipient of Concurrent Pancreas-Kidney Transplantation With Type 1 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Takahiro","family":"Kawaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Jinno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohide","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3180","article-title":"SGLT2 inhibition--a novel strategy for diabetes treatment","volume":"9","author":"Chao EC","year":"2010","unstructured":"Chao EC, Henry RR. SGLT2 inhibition--a novel strategy for diabetes treatment. Nat Rev Drug Discov. 2010, 9:551-9. 10.1038\/nrd3180","journal-title":"Nat Rev Drug Discov"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman B","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al.. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015, 373:2117-28. 10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer M","year":"2020","unstructured":"Packer M, Anker SD, Butler J, et al.. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020, 383:1413-24. 10.1056\/NEJMoa2022190","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.11.002","article-title":"SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis","volume":"38","author":"Goldenberg RM","year":"2016","unstructured":"Goldenberg RM, Berard LD, Cheng AY, Gilbert JD, Verma S, Woo VC, Yale JF. SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis. Clin Ther. 2016, 38:2654-64.e1. 10.1016\/j.clinthera.2016.11.002","journal-title":"Clin Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.03.028","article-title":"Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review","volume":"123","author":"Thiruvenkatarajan V","year":"2019","unstructured":"Thiruvenkatarajan V, Meyer EJ, Nanjappa N, Van Wijk RM, Jesudason D. Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019, 123:27-36. 10.1016\/j.bja.2019.03.028","journal-title":"Br J Anaesth"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.06.006","article-title":"Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter-2 inhibitors - lessons from a case series and strategies to decrease incidence","volume":"28","author":"Mehta PB","year":"2022","unstructured":"Mehta PB, Robinson A, Burkhardt D, Rushakoff RJ. Inpatient perioperative euglycemic diabetic ketoacidosis due to sodium-glucose cotransporter-2 inhibitors - lessons from a case series and strategies to decrease incidence. Endocr Pract. 2022, 28:884-8. 10.1016\/j.eprac.2022.06.006","journal-title":"Endocr Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2020_545","article-title":"Acute metabolic emergencies in diabetes: DKA, HHS and EDKA","author":"Muneer M","year":"2020","unstructured":"Muneer M, Akbar I. Acute metabolic emergencies in diabetes: DKA, HHS and EDKA. Diabetes: From Research to Clinical Practice. Islam MS (ed): Springer, Cham, Switzerland; 2020. 85-114. 10.1007\/5584_2020_545"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14251","article-title":"Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations","volume":"73","author":"Milder DA","year":"2018","unstructured":"Milder DA, Milder TY, Kam PC. Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations. Anaesthesia. 2018, 73:1008-18. 10.1111\/anae.14251","journal-title":"Anaesthesia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2805098","article-title":"SGLT2i in patients with type 1 diabetes: benefits, risks, and preventive strategies","volume":"28","author":"Ma Y","year":"2023","unstructured":"Ma Y, Zhao Q, Peng H, Nalisa DL, Shan P, Jiang H. SGLT2i in patients with type 1 diabetes: benefits, risks, and preventive strategies. Front Biosci (Landmark Ed). 2023, 28:98. 10.31083\/j.fbl2805098","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231152236","article-title":"Update on measuring ketones","volume":"18","author":"Huang J","year":"2024","unstructured":"Huang J, Yeung AM, Bergenstal RM, et al.. Update on measuring ketones. J Diabetes Sci Technol. 2024, 18:714-26. 10.1177\/19322968231152236","journal-title":"J Diabetes Sci Technol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000000894","article-title":"Comprehensive review of diabetic ketoacidosis: an update","volume":"85","author":"Elendu C","year":"2023","unstructured":"Elendu C, David JA, Udoyen AO, et al.. Comprehensive review of diabetic ketoacidosis: an update. Ann Med Surg (Lond). 2023, 85:2802-7. 10.1097\/MS9.0000000000000894","journal-title":"Ann Med Surg (Lond)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4158\/EP161292.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis","volume":"22","author":"Handelsman Y","year":"2016","unstructured":"Handelsman Y, Henry RR, Bloomgarden ZT, et al.. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016, 22:753-62. 10.4158\/EP161292.PS","journal-title":"Endocr Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.02.039","article-title":"Current practice in the perioperative management of patients with diabetes mellitus: a narrative review","volume":"131","author":"Crowley K","year":"2023","unstructured":"Crowley K, Scanaill P\u00d3, Hermanides J, Buggy DJ. Current practice in the perioperative management of patients with diabetes mellitus: a narrative review. Br J Anaesth. 2023, 131:242-52. 10.1016\/j.bja.2023.02.039","journal-title":"Br J Anaesth"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-023-03174-8","article-title":"Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports","volume":"37","author":"Seki H","year":"2023","unstructured":"Seki H, Ideno S, Shiga T, et al.. Sodium-glucose cotransporter 2 inhibitor-associated perioperative ketoacidosis: a systematic review of case reports. J Anesth. 2023, 37:465-73. 10.1007\/s00540-023-03174-8","journal-title":"J Anesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393260-sodium-glucose-co-transporter-2-inhibitor-associated-euglycemic-diabetic-ketoacidosis-in-a-recipient-of-concurrent-pancreas-kidney-transplantation-with-type-1-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T10:20:38Z","timestamp":1754994038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393260-sodium-glucose-co-transporter-2-inhibitor-associated-euglycemic-diabetic-ketoacidosis-in-a-recipient-of-concurrent-pancreas-kidney-transplantation-with-type-1-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.89866","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}